What Immunotherapy Combination Is Best in Metastatic Bladder Cancer?
November 15th 2018Extended follow-up from the CheckMate 032 trial showed strong results with three different immunotherapy regimens involving nivolumab and ipilimumab in patients with previously treated metastatic urothelial carcinoma.